Trump nominee to head up FDA made no commitments on abortion pill access
WASHINGTON — President Donald Trump’s nominee to lead the Food and Drug Administration refused to commit to keeping access to medication abortion as it is now, or changing prescribing guidelines, in response to questions from both Democrats and Republicans during his confirmation hearing Thursday.
Trump's FDA nominee tepidly backs role for vaccine advisers in guarded Senate appearance
Martin Makary, President Donald Trump's nominee to run the U.S. FDA, told lawmakers on Thursday he would convene a committee of vaccine advisers but said he would reevaluate which scientific issues require their input.
President Donald Trump’s pick to lead the Food and Drug Administration largely sidestepped questions Thursday from senators ...
Chemicals such as titanium dioxide and potassium bromate, whose safety has been debated, are allowed in foods in the United ...
In particular, AI could assist FDA staff to review drug and device applications, he told senators on the Health, Education, ...
For communications leaders across industries, this initiative underscores the critical importance of crafting clear messaging ...
Medpage Today on MSN2d
FDA Approves Ocular Implant for Vision-Threatening MacTelThe FDA approved revakinagene taroretcel (Encelto) as the first treatment for adults with idiopathic macular telangiectasia ...
MyChesCo on MSN59m
FDA Approves Lifesaving Stroke Drug, Xarelto Generics, and Issues Urgent Testosterone WarningsThe U.S. Food and Drug Administration (FDA) has released several important updates addressing new medication approvals and ...
The Amazon Fresh cookie recall is an FDA Class I recall due to undeclared egg allergens. Here’s why it took time to surface and if it may still poses a risk.
PTC Therapeutics could boost revenue with vatiquinone for Friedreich's ataxia. Find out why PTCT stock is poised for growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback